Shanghai, China — From July 11–13, 2025, Singclean Medical will proudly participate in IMCAS China 2025, one of Asia’s most influential aesthetic medicine congresses. As a key highlight, Singclean will host the First Singclean International Aesthetic Leadership Forum on July 12 at the Grand Hyatt Shanghai, under the theme:
“Academic Vision · Aesthetic Future.”
This landmark forum will bring together top-tier enterprise leaders, clinical experts, and academic pioneers from around the world to explore the evolving aesthetic ecosystem, global market strategy, raw material innovation, and the sustainable future of aesthetic medicine.
Keynote Highlights
Singclean Global 3.0 Strategy Release
Outlining Singclean’s next-phase vision for a connected, regenerative, and clinically driven global aesthetic ecosystem.BD Global Strategy Presentation (TBD)
Exploring the application of BDHylokM as a platform for global injection innovation.HTL Keynote: Global Applications of Pharmaceutical-Grade Hyaluronic Acid (TBD)
Presented by the Head of HTL China, this session will explore how medical-grade HA is shaping clinical safety and product performance worldwide.Special Address: “The Quality Pyramid”
A deep dive into transforming trusted consultation into long-term strategic partnership.
Two major milestone events will also take place:
Singclean Brand Signing Ceremony
Singclean Global Partnership Program Launch
Featured Speaker: Dr. Liu Linlin Live at IMCAS
On July 13, Dr. Liu Linlin, a respected name in clinical aesthetics, will speak on behalf of Singderm, sharing her injection strategies using highly viscoelastic sodium hyaluronate gel to enhance original facial structures.
Location: Kerry Hotel Pudong, Shanghai
Time: 13:30–13:50
Room 1, Level 3
Her presentation will cover:
Personalized strategies for Asian facial anatomy
Use of advanced HA+ gel for lifted, natural results
Artistic balance between structure, elasticity, and safety
This session is a must-attend for injectors, aesthetic doctors, and clinical leaders looking to stay at the forefront of precision-based filler techniques.
Global Collaboration · Quality First
Singclean Medical remains firmly committed to sourcing excellence, working with world-renowned raw material partners like HTL to ensure the integrity, safety, and performance of its medical aesthetic solutions.
By establishing a high-standard, traceable global supply chain, Singclean aims to lead in both product innovation and responsible development across the industry.
Let’s Co-Create the Future of Beauty
Join us in Shanghai for a two-day experience of dialogue, discovery, and direction-setting for the future of global aesthetic science.
Forum: July 12, 2025
Dr. Liu Linlin’s Session: July 13, 2025
Venue: Grand Hyatt Shanghai & Kerry Hotel Pudong
Singclean Booth No. 64
-
singclean | 2025-06-30Singclean Medical to Showcase Breakthrough Aesthetic Solutions at IMCAS China 2025Shanghai, China – Singclean Medical is proud to announce its participation in IMCAS China 2025, one of Asia’s leading congresses for medical aesthetics, taking place from July 11 to 13 at the Kerry Hotel Pudong, Shanghai.
-
singclean | 2025-06-30Singclean Medical shines at HOSPITALAR 2025: Deeply cultivate the Latin American medical market with R&D and intelligent manufacturingSao Paulo, Brazil —— Singclean Medical, a world-leading absorbable biomaterial company, appeared at HOSPITALAR 2025 in June 2025, bringing four major product lines including regenerative medical beauty, orthopedics, ophthalmology and surgical hemostasis, to systematically demonstrate its global strength driven by the dual core of "R&D + automation" to the Latin American market. As a benchmark exhibition in the Latin American medical industry, this HOSPITALAR brings together top companies from around the world. Singclean Medica has become one of the core concerns of professional audiences on site with its CE/NMPA/ANVISA multi-certified product matrix and localized cooperation results.
-
singclean | 2025-06-30Singclean Medical to Showcase Pioneering Aesthetic Solutions at HOSPITALAR 2025